ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Vienna Insurance Group (PK)

Vienna Insurance Group (PK) (VNRFY)

5.81
0.00
(0.00%)
Closed January 13 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.81
Bid
5.78
Ask
6.69
Volume
-
0.00 Day's Range 0.00
5.50 52 Week Range 7.16
Market Cap
Previous Close
5.81
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
425
Shares Outstanding
640,000,000
Dividend Yield
3.33%
PE Ratio
34.52
Earnings Per Share (EPS)
0.87
Revenue
3.37B
Net Profit
558.98M

About Vienna Insurance Group (PK)

Sector
Ins Agents,brokers & Service
Industry
Fire, Marine, Casualty Ins
Website
Headquarters
Vienna, Aut
Founded
1998
Vienna Insurance Group (PK) is listed in the Ins Agents,brokers & Service sector of the OTCMarkets with ticker VNRFY. The last closing price for Vienna Insurance (PK) was $5.81. Over the last year, Vienna Insurance (PK) shares have traded in a share price range of $ 5.50 to $ 7.16.

Vienna Insurance (PK) currently has 640,000,000 shares outstanding. The market capitalization of Vienna Insurance (PK) is $3.72 billion. Vienna Insurance (PK) has a price to earnings ratio (PE ratio) of 34.52.

VNRFY Latest News

AXA to Sell Hungarian Life, Savings Insurance Business

By Nadya Masidlover PARIS--French insurance company AXA SA (CS.FR) said Monday it has signed an agreement to sell its Hungarian life and savings insurance businesses to Vienna Insurance Group...

Ex-Dividend

Tue, May 07, 2013 08:00 - Vienna Insurance Group (VNRFY: OTC Link) - Ex-Dividend - As of Wed, May 08, 2013, Vienna Insurance Group traded ex-dividend. Vienna Insurance Group will disburse a Cash...

Scheduled Ex-Dividend

Tue, Apr 16, 2013 08:00 - Vienna Insurance Group (VNRFY: OTC Link) - Scheduled Ex-Dividend - Vienna Insurance Group has announced a dividend ex-date for (VNRFY: OTC Link). Vienna Insurance Group...

Austrian Regulator Extends Restriction On Short Selling

Austria's financial regulator extended a ban on naked short selling for some Austrian financial institutions until May 31, 2012, the Austrian Financial Market Authority said Tuesday. The ban on...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
12-0.73-11.16207951076.546.545.794256.17242353DR
26-0.365808-5.923241137036.1758086.6655.7914296.48350184DR
520.315.636363636365.57.165.57436.44312877DR
156-0.098-1.658767772515.9087.164.275875.93017352DR
2600.16452.913825170495.64557.163.0914145.0559367DR

VNRFY - Frequently Asked Questions (FAQ)

What is the current Vienna Insurance (PK) share price?
The current share price of Vienna Insurance (PK) is $ 5.81
How many Vienna Insurance (PK) shares are in issue?
Vienna Insurance (PK) has 640,000,000 shares in issue
What is the market cap of Vienna Insurance (PK)?
The market capitalisation of Vienna Insurance (PK) is USD 3.72B
What is the 1 year trading range for Vienna Insurance (PK) share price?
Vienna Insurance (PK) has traded in the range of $ 5.50 to $ 7.16 during the past year
What is the PE ratio of Vienna Insurance (PK)?
The price to earnings ratio of Vienna Insurance (PK) is 34.52
What is the cash to sales ratio of Vienna Insurance (PK)?
The cash to sales ratio of Vienna Insurance (PK) is 5.72
What is the reporting currency for Vienna Insurance (PK)?
Vienna Insurance (PK) reports financial results in EUR
What is the latest annual turnover for Vienna Insurance (PK)?
The latest annual turnover of Vienna Insurance (PK) is EUR 3.37B
What is the latest annual profit for Vienna Insurance (PK)?
The latest annual profit of Vienna Insurance (PK) is EUR 558.98M
What is the registered address of Vienna Insurance (PK)?
The registered address for Vienna Insurance (PK) is SCHOTTENRING 30, VIENNA, 1010
What is the Vienna Insurance (PK) website address?
The website address for Vienna Insurance (PK) is www.vig.com
Which industry sector does Vienna Insurance (PK) operate in?
Vienna Insurance (PK) operates in the FIRE, MARINE, CASUALTY INS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
$ 0.00025
(-16.67%)
129.87M

Discussion

View Full Feed
sunspotter sunspotter 14 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 25 minutes ago
Marc loved your ides
tinojax tinojax 26 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 28 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 44 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 44 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 45 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 46 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 53 minutes ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 56 minutes ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 1 hour ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 1 hour ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 1 hour ago
He would smother any question with words.
Shawonsarker84 Shawonsarker84 1 hour ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 1 hour ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 1 hour ago
Oh noooooo.....
FNMA
StockItOut StockItOut 1 hour ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 2 hours ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL